Clinical Trial Update: Brazilian Reality of Hepatocellular Carcinoma

View source ↗

Summary

AstraZeneca-sponsored hepatocellular carcinoma trial conducted in Brazil has completed, with analyses by BCLC stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: AstraZeneca | Conditions: Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage | Status: COMPLETED